Table 2.
Univariate analysis of OS in the patients.
| Variables | OS |
|
|---|---|---|
| HR (95%CI) | P-value | |
| EGFL7 (high vs. Low) | 1.789 (1.020–3.137) | .042 |
| Age (≥60 vs. <60 years) | 1.406 (0.769–2.571) | .268 |
| WBC (≥15 vs. <15 × 109/L) | 1.161 (0.665–2.028) | .600 |
| BM blasts (≥70 vs. <70%) | 0.840 (0.487–1.449) | .530 |
| PB blasts (≥20 vs. <20%) | 1.121 (0.607–2.071) | .716 |
| FLT3-ITD (positive vs. negative) | 1.666 (0.884–3.139) | .114 |
| NPM1 (mutated vs. wild) | 0.805 (0.422–1.536) | .510 |
| DNMT3A (mutated vs. wild) | 1.259 (0.668–2.374) | .477 |
| RUNX1 (mutated vs. wild) | 2.437 (1.127–5.270) | .024 |
| TP53 (mutated vs. wild) | 4.270 (1.437–12.688) | .009 |
| MLL-PTD (positive vs. negative) | 3.307 (1.171–9.334) | .024 |
Abbreviations: OS, Overall survival; HR, hazard ratio; CI, confidence interval; WBC, white blood cell; BM, bone marrow; PB, peripheral blood.